Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RARE DISEASE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06790706
What this trial is testing

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

Who this might be right for
Peritoneal MesotheliomaGestational Trophoblastic TumorAnaplastic Thyroid Carcinomas+3 more
Hospices Civils de Lyon 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04261855
What this trial is testing

Targeted Therapy and Avelumab in Merkel Cell Carcinoma

Who this might be right for
Metastatic Merkel Cell Carcinoma
Melanoma and Skin Cancer Trials Limited 19
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableEnded earlyNCT05022420
What this trial is testing

SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases

Who this might be right for
ToleranceBiopsy Site Itching
University Hospital, Brest 505
Testing effectiveness (Phase 2)Ended earlyNCT05215951
What this trial is testing

Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLC

Who this might be right for
Lung Cancer
AstraZeneca 4
Early research (Phase 1)Study completedNCT04765553
What this trial is testing

Evaluate Emapalumab in Japanese Healthy Volunteers.

Who this might be right for
Rare Diseases
Swedish Orphan Biovitrum 8
Early research (Phase 1)UnknownNCT00004368
What this trial is testing

Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis

Who this might be right for
CirrhosisLiver Cirrhosis
National Center for Research Resources (NCRR) 15
Not applicableEnrolling By InvitationNCT01440218
What this trial is testing

Idiopathic Diseases of Man

Who this might be right for
Rare DiseaseIdiopathic Disease
Scripps Translational Science Institute 10
Not applicableLooking for participantsNCT06353620
What this trial is testing

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Who this might be right for
EpilepsyAngelman SyndromeDup15q Syndrome
IRCCS Eugenio Medea 120
Not applicableStudy completedNCT05712564
What this trial is testing

Fatigue, Depressive Disorders and Insomnia in Adult Patients with Marfan Syndrome and Ehlers-Danlos Syndrome: Survey

Who this might be right for
Rare DiseasesFatigueInsomnia+1 more
IRCCS Policlinico S. Donato 282
Not applicableActive Not RecruitingNCT07202260
What this trial is testing

Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (SCLC)
The Christie NHS Foundation Trust 80
Not applicableStudy completedNCT00004449
What this trial is testing

Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism

Who this might be right for
Autistic Disorder
University of California, Los Angeles 102
Not applicableStudy completedNCT01142674
What this trial is testing

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma, T-Cell, Peripheral
Associazione Angela Serra per la ricerca sul cancro 1,650
Not applicableLooking for participantsNCT06360913
What this trial is testing

Blood Spot and Urine Metabolomic Screening Applied to Rare Diseases

Who this might be right for
Inborn Errors of MetabolismRare Diseases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2,286
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Testing effectiveness (Phase 2)Looking for participantsNCT06706076
What this trial is testing

BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
BlossomHill Therapeutics 675
Not applicableStudy completedNCT01170559
What this trial is testing

Use of Loop Recorders for Diagnosis of Palpitations in A&E

Who this might be right for
Palpitations
Barts & The London NHS Trust 56
Not applicableStudy completedNCT00005893
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

Who this might be right for
NeutropeniaSickle Cell AnemiaThalassemia Major+1 more
Fairview University Medical Center
Not applicableLooking for participantsNCT04504604
What this trial is testing

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

Who this might be right for
Rare CancersCholangiocarcinomaCancer of Unknown Primary Site
TargetCancer Foundation 400
Not applicableLooking for participantsNCT07372833
What this trial is testing

CAMK2-related Synapthopathies Natural History Study

Who this might be right for
CAMK2Calcium/Calmodulin-dependent Protein Kinase 2
Erasmus Medical Center 150
Next Page